Ifp Advisors, Inc Arch Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $2.42 Billion
- Q2 2024
About Arch Therapeutics, Inc.
- Ticker ARTH
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 249,886,000
- Market Cap $62.5M
- Description
- Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...